Please Share:: 
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Result Preview
Aventis Pharma – 4QCY2010
Aventis Pharma is scheduled to announce its 4QCY2010E results. We expect net sales to
increase by 10.8% to `263cr for the quarter. The company is likely to post 40.4% growth in
net profit, on the back of a 668bp yoy improvement in OPM, compared to the last
corresponding period, which was marred by a decline in the domestic formulation business.
We currently have a Neutral recommendation on the stock
India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��
Result Preview
Aventis Pharma – 4QCY2010
Aventis Pharma is scheduled to announce its 4QCY2010E results. We expect net sales to
increase by 10.8% to `263cr for the quarter. The company is likely to post 40.4% growth in
net profit, on the back of a 668bp yoy improvement in OPM, compared to the last
corresponding period, which was marred by a decline in the domestic formulation business.
We currently have a Neutral recommendation on the stock
No comments:
Post a Comment